Whilst whole body (WB) MRI offers substantial promise in cancer staging, considerations regarding image quality are lacking in the literature, yet are essential for the effective delivery of the technique. Here we report the image quality of WB-MRI in 86 patients with suspected biochemical recurrence in prostate cancer in a trial carried out over 3 continents (Australia, America and Europe). We show that the image quality of WB-MRI varies substantially between anatomical sites and centres, particularly for diffusion-weighted sequences, which emphasizes the need to optimise sequences carefully prior to establishing a WB-MRI practice.
This abstract and the presentation materials are available to members only; a login is required.